Sarfez Pharmaceuticals, Inc.
Clinical trials sponsored by Sarfez Pharmaceuticals, Inc., explained in plain language.
-
New pill may ease bladder woes in heart failure patients
Symptom relief CompletedThis study tested whether an extended-release form of the water pill torsemide works better than the standard version for heart failure patients who also have overactive bladder symptoms. 24 adults aged 50 and older with chronic heart failure took each version for four weeks and …
Phase: PHASE2 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 11:17 UTC
-
New water pill formula may help heart patients better flush salt
Symptom relief CompletedThis study tested whether a long-acting version of the water pill torsemide helps people with heart failure get rid of more salt after lunch compared to the standard version. Twenty adults with stable heart failure took both types of pills on different days to compare their effec…
Phase: PHASE4 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
New combo pill for fluid retention put to the test
Knowledge-focused CompletedThis study looked at how a new extended-release tablet combining two heart medications (torsemide and spironolactone) works in 24 healthy adults. The goal was to see if the combination pill is absorbed the same way as taking the drugs separately. This helps ensure the new pill is…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 11:19 UTC
-
Does breakfast change your medicine? study tests heart drug combo with and without food
Knowledge-focused CompletedThis study looked at how taking a fixed-dose combination of two heart failure drugs (torsemide and spironolactone) with or without food changes the amount of drug that gets into the body. 24 healthy adults aged 18-45 took a single dose under both conditions. The goal was to see i…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
New combo pill tested in healthy volunteers – no treatment given
Knowledge-focused CompletedThis study looked at how a new extended-release tablet combining two heart medications (torsemide and spironolactone) is absorbed and processed by the body. It involved 24 healthy adults aged 18 to 45. The goal was to measure drug levels in blood and urine, not to treat any disea…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC